Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging

Journal of Magnetic Resonance Imaging : JMRI
Martin RauschMarkus Rudin

Abstract

To examine the efficacy of FTY720 as a new agent to reduce inflammatory activity in an animal model of multiple sclerosis (MS) by in vivo macrophage tracking. FTY720 was used for treatment of rats in a model of chronic relapsing experimental autoimmune encephalomyelitis (EAE) at an oral dose of 0.3 mg/kg/day. Magnetic resonance imaging (MRI) based on in vivo tracking of macrophages labeled with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles, immunohistological staining (IHC), and neurological readouts was used to study the burden of disease in treated and untreated animals. While untreated animals showed severe paralysis of the hind paws, intense accumulation of macrophages in brain tissue, and areas of blood-brain barrier (BBB) disruption, FTY720-treated animals displayed no signs of inflammatory activity or neurological impairment. These observations were made for both acute phase and first relapse. Tracking of macrophages by MRI provides direct evidence of the immunomodulatory efficacy of FTY720 in the EAE model and correlates well with neurological symptoms and histology.

References

Feb 1, 1991·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·P S Tofts, A G Kermode
Dec 1, 1985·Journal of Neuroimmunology·C FeurerS Cammisuli
Jan 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·J W BulteL de Leij
Apr 29, 1998·Brain : a Journal of Neurology·D H MillerH F McFarland
Jul 11, 1998·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·E T AhrensR E Jacobs
Mar 18, 1999·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·V DoussetJ M Caillé
Jul 30, 1999·Journal of Neuroimmunology·R M Ransohoff
Dec 22, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·F Barkhof, M van Walderveen
Feb 9, 2000·Trends in Pharmacological Sciences·V BrinkmannL Feng
Feb 23, 2000·Journal of Neuroimmunology·D A SipkinsL Steinman
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D D PinschewerR M Zinkernagel
Oct 25, 2001·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M RauschM Rudin
Mar 20, 2002·Current Neurology and Neuroscience Reports·S Markovic-Plese, H F McFarland
Apr 23, 2002·The Journal of Biological Chemistry·Volker BrinkmannKevin R Lynch
Jun 5, 2002·Current Opinion in Neurology·Bernhard HemmerNorbert Sommer
Aug 17, 2002·Current Opinion in Immunology·Volker Brinkmann, Kevin R Lynch
Oct 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Dean M AnselmoDouglas G Farmer
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Masayuki FujinoXiao-Kang Li
Jul 24, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M RauschM Rudin

❮ Previous
Next ❯

Citations

Nov 8, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Thomas Tourdias, Vincent Dousset
Jun 30, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Klaus G PetryBruno Brochet
Nov 30, 2005·Transplantation·Jin Young KimChul Woo Yang
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·David J Virley
Aug 1, 2012·International Journal of Nanomedicine· Wahajuddin, Sumit Arora
Sep 19, 2006·Drugs·Helio Tedesco SilvaJose Osmar Medina Pestana
May 25, 2007·CNS Drugs·Bernd C Kieseier, Heinz Wiendl
Jan 11, 2014·Immunology Letters·Xavier Clemente-Casares, Pere Santamaria
Jun 6, 2013·Mediators of Inflammation·David H TianGila Moalem-Taylor
May 7, 2008·Expert Review of Neurotherapeutics·Alejandro Horga, Xavier Montalban
Feb 17, 2007·Expert Opinion on Investigational Drugs·Thomas BaumrukerVolker Brinkmann
Jun 15, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jens IngwersenHans-Peter Hartung
Apr 28, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sachi TsunemiHajime Sano
Apr 7, 2010·Clinical Neurology and Neurosurgery·Reza Vosoughi, Mark S Freedman
Jul 7, 2009·Pharmacology & Therapeutics·Andrea Huwiler, Josef Pfeilschifter
Jun 30, 2009·Revue neurologique·T TourdiasV Dousset
Oct 8, 2009·Prostaglandins & Other Lipid Mediators·Rochelle P CoelhoCarmen Sato-Bigbee
Sep 17, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jason S WeinsteinEdward A Neuwelt
Jul 26, 2008·Journal of Neuroimmunology·Yutong LiuMichael D Boska
Aug 6, 2008·Journal of the Neurological Sciences·Veronique E MironJack P Antel
Nov 30, 2005·Journal of Neurochemistry·Harsimran S SainiCarmen Sato-Bigbee
May 10, 2007·Journal of Cellular and Molecular Medicine·Zhiyuan ZhangHermann J Schluesener
Mar 5, 2011·British Journal of Pharmacology·Cris S ConstantinescuBruno Gran
Oct 19, 2011·Journal of Neurochemistry·Rachel WilliamsSteven M LeVine
Apr 18, 2015·Contrast Media & Molecular Imaging·Shahriar SharifiMorteza Mahmoudi
Apr 22, 2014·Expert Opinion on Therapeutic Patents·Alberto LeoniMirella Rambaldi
Jul 25, 2009·Immunobiology·Andreas WeigertBernhard Brüne
Dec 3, 2014·American Heart Journal·John CammVolker Brinkmann
Dec 17, 2014·Frontiers in Cellular Neuroscience·Maxime GaubertiDenis Vivien
Nov 23, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Nabeela NathooJeff F Dunn
Oct 21, 2015·Magnetic Resonance Insights·Daniel J KorchinskiJeff F Dunn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Masayuki FujinoXiao-Kang Li
The New England Journal of Medicine
L KapposFTY720 D2201 Study Group
Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine
Martin RauschMarkus Rudin
© 2022 Meta ULC. All rights reserved